• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

MitoPharm Targets Baby Boomers, Positions Functional Beverages, Dietary Supplements and Drugs- MitoPharm's Anti-Aging Products for the Baby Boom Generation

Posted on: Wednesday, 23 May 2007, 09:00 CDT

MitoPharm Corporation, Inc. (Pink Sheets:MTPM). The Baby Boom generation, some 78 million consumers strong, the wealthiest generation in history turns 60, and MitoPharm has positioned itself with its anti-aging products to attract some of that wealth, by making boomers lives better. As a group, they've got a lot of money to spend; altogether they earn an estimated two trillion dollars a year.

Prospects for the $59 billion anti-aging market have never been brighter. With health-care costs rising, aging Baby Boomers and all other Americans are looking for ways to promote their own good health and avoid illness. About half of all U.S. consumers use vitamins and nutritional supplements and this percentage will rise as more consumers become educated about the value of these products. So the potential market for MitoPharm is huge.

MitoPharm products are about anti-aging and stamina improvement. The key ingredient of the products is a novel compound Shisandrin B which is the result of over 15 years of research and development by one of its founding shareholders, the Hong Kong University of Science and Technology (HKUST). There are over 67 research papers published on the Compound; all consistently corroborating its remarkable biochemical properties in counteracting aging and improving body stamina.

Restorade - Available as a functional beverage or as a soft-gel capsule, the scientifically optimized provides holistic anti-aging benefits:

Counteracts directly and effectively the leading cause of aging -- mitochondrial decay, and simultaneously increases cellular anti-oxidant capacity.

Enhances mitochondrial functional capacity of vital organs - delivering improved and balanced health as added benefits.

Functional benefits well supported by science.

Not hormonal stimulants/replenishments, nor merely anti-oxidants

Stamina Solution - Available as functional drink and as soft-gel capsule, the patent pending formula of Stamina Solution delivers long-term and balanced energy improvement

Improves stamina through rejuvenation of functional capacities of vital organs.

Increases exercise performance and endurance by (i) enhancement of the metabolism of liver glutathione and, (ii) rejuvenated innate body conditions.

Protects skeletal muscles from exercise-induced injuries through (i) the induction of the expression of Heat Shock Proteins and, (ii) enhancement of the metabolism of the liver glutathione.

Functional benefits well supported by science.

Not a short-term alertness stimulant.

About the Company

MitoPharm Corporation is a biotechnology company in the research & development, marketing and sale of drugs, dietary supplements, and functional beverages. The initial products are based on a newly discovered compound (the "Compound") that is the result of over 15 years of research and development by one of its founding shareholders, the Hong Kong University of Science and Technology ("HKUST"). www.ust.hk

At HKUST, scientific studies have identified biochemical actions of MitoPharm's key Compound, demonstrating that it enhances the mitochondrial glutathione antioxidant status, a crucial factor in maintaining mitochondrial function and cell survival, and also induces the expression of heat shock proteins, another group of important molecules for cell protection. Management's research indicates that these biochemical actions differentiate the Compound from other existing, known compounds, either synthetic or naturally occurring, in its ability to protect organs including the heart, the liver, and the brain. www.mitopharm.com

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations, are generally identifiable by the use of words such as "believe,""expect,""intend,""anticipate,""estimate,""project," or similar expressions. These forward-looking statements relate to, among other things, expectations of the business environment in which the Company operates, projections of future performance, potential future performance, perceived opportunities in the market, and statements regarding the Company's mission and vision. The Company's actual results, performance, and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements.

To join MitoPharm's email list please click at the following link

http://www.b2i.us/irpass.asp?BzID=1509&to=ea&s=0

Source: Business Wire

More News in this Category